xml version="1.0" encoding="utf-8"?          zbh-8k_20210205.htm    

   false 0001136869        0001136869   2021-02-05 2021-02-05     0001136869  us-gaap:CommonStockMember    2021-02-05 2021-02-05     0001136869  zbh:OnePointFourOneFourPercentageNotesDueTwoThousandTwentyTwoMember    2021-02-05 2021-02-05     0001136869  zbh:TwoPointFourTwoFivePercentageNotesDueTwoThousandTwentySixMember    2021-02-05 2021-02-05     0001136869  zbh:OnePointOneSixFourPercentageNotesDueTwoThousandTwentySevenMember    2021-02-05 2021-02-05      

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 8-K 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported): February 5, 2021 

ZIMMER BIOMET HOLDINGS, INC. 

(Exact name of registrant as specified in its charter) 

 [DATA_TABLE_REMOVED] 

345 East Main Street 

Warsaw, Indiana 46580 

(Address of principal executive offices) (Zip Code) 

Registrant’s telephone number, including area code: (574) 267-6131 

Not applicable 

(Former name or former address, if changed since last report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 

☐  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  

☐  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  

☐  

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  

☐  

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   

Securities registered pursuant to Section 12(b) of the Act: 

 [DATA_TABLE_REMOVED] 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)  

Emerging growth company ☐ 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ 

Item 2.02Results of Operations and Financial Condition. 

On February 5, 2021, Zimmer Biomet Holdings, Inc. (the “Company”) issued a press release reporting its financial results for the quarter and year ended December 31, 2020. A copy of the press release is attached as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report.  

The information contained in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” with the Securities and Exchange Commission (the “SEC”) for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. 

Item 7.01  

Regulation FD Disclosure. 

On February 5, 2021, the Company issued a press release announcing its intention to spin off its Spine and Dental businesses. A copy of the press release is attached as Exhibit 99.2 and the information set forth therein is incorporated herein by reference and constitutes a part of this report. 

The information contained in this Item 7.01, including Exhibit 99.2, is being furnished and shall not be deemed to be “filed” with the SEC for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section and is not incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. 

Item 9.01  

Financial Statements and Exhibits. 

(d)  

Exhibits 

 [DATA_TABLE_REMOVED] 

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

Dated: February 5, 2021 

 [DATA_TABLE_REMOVED]